![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 04, 2010 3:35:46 PM
I specialize in treatment of the spine and am certified in the McKenzie Method (http://www.mckenziemdt.org/index_us.cfm). This method is the most reliable way to determine what "subgroup" of back pain you are dealing with and therefore what "treatment" will most likely be effetive in relieving it. Think of it this way: before doctors were able to culture bacteria, they would choose whatever antibiotic they thought was right without knowing if it would work. Therefore many people would not only not get better but possibly be made worse or even die because of incorrect treatment. Cultures allow exact pairing of condition and treatment. The McKenzie Method is the same - but for the spine...and it sure has made my life easier as a physical therapist!
However, there are patients that do not respond to treatment and the McKenzie Method identifies them as non-responders. Guess what - these people are prime TENS candidates, as are those who want to get off or reduce their pain meds. This is the subgroup that TENS works phenomenally on. So do I give it for all chronic back pain sufferers? Nope! McKenzie usually fixes them first. but when it doesn't they do great with TENS.
By the way, if you guys have or know someone who has back problems, check out that website and use the therapist locator for someone in your area who can help. The McKenzie Method is the best thing going in the world of conservative back care. Not IMO - in the evidence and research which is a lot better than the crap like this study that the news networks quote just to paste something on their sites.
Oh and thanks Raw, I still long...
Ehren
Recent ZYXI News
- Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces • PR Newswire (US) • 07/11/2024 01:15:00 PM
- Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 • PR Newswire (US) • 06/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:24:18 PM
- Zynex to Present at the RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/09/2024 01:15:00 PM
- Zynex Executives Recognized Among Top 25 in Medical Technology • PR Newswire (US) • 05/07/2024 01:15:00 PM
- Zynex Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:01:00 PM
- Zynex Sets First Quarter 2024 Earnings Call • PR Newswire (US) • 04/18/2024 01:15:00 PM
- Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award • PR Newswire (US) • 04/02/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:15:17 PM
- Zynex Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:01:00 PM
- Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call • PR Newswire (US) • 02/22/2024 02:15:00 PM
- Zynex Introduces New Products • PR Newswire (US) • 02/20/2024 02:15:00 PM
- Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 • GlobeNewswire Inc. • 02/08/2024 02:00:00 PM
- Zynex Receives FDA Clearance for its Next Generation NMES Device • PR Newswire (US) • 02/06/2024 02:15:00 PM
- Zynex Recognized in Top 25 Medical Device Companies for 2024 • PR Newswire (US) • 02/02/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 10:55:32 PM
- Zynex to Participate at the Needham Annual Growth Conference • PR Newswire (US) • 01/08/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:15:06 PM
- Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024" • PR Newswire (US) • 11/15/2023 02:15:00 PM
- Zynex Submits FDA Application for its Next Generation NMES Device • PR Newswire (US) • 11/13/2023 02:15:00 PM
- Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year • PR Newswire (US) • 11/09/2023 02:15:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM